High dose chemotherapy and transplantation of patients' own blood stem cells may be more effective than standard treatment with the approved drug Mitoxantrone in severe affected patients with Multiple Sclerosis , according to a new study published in the online issue of Neurology , the medical journal of the American Academy of Neurology. The study was supported by the European Society for Blood and Marrow Transplantation and all the members of the Autoimmune Diseases Working Party as well as the EBMT Clinical Trials Officers.
http://ift.tt/1GGqQkH
http://ift.tt/1GGqQkH
No comments:
Post a Comment